3M(TM) Filtek(TM) Supreme Flowable Composites for Class IV and Veneers
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorNew York University
About this trial
This clinical study aims to evaluate the clinical performance of 3M™ Filtek™ Supreme Flowable Composite in class IV and veneer indication. Follow-ups of 7 days, 6, 12, and 24 months will be conducted following an Fédération Dentaire Internationale (FDI) modified score (2023). A minimum of 50 Class IV and 25 veneers will be included in the evaluation. Research data and pictures will be provided for each patient pre-op and at 7 days (baseline, 6 months, 12 months and 24 months. Evaluation will be conducted by two calibrated evaluators different from the operator according to FDI clinical criteria.
Eligibility criteria
Qualifiers
Age between 18 -75 years old
must be willing and able to provide informed consent to participate in the study
must be available for the required post-operative follow-up study visits
must be in good general health
Disqualifiers
Single tooth veneers
Canines
Periodontal disease
Pulpal diseases
Trial design
Treatments tested in this trial
- 3MTM FiltekTM Supreme Flowable Composite
Treatment groups
75 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov